Advertisement

Acta Diabetologica

, Volume 47, Supplement 1, pp 77–81 | Cite as

Continuous subcutaneous insulin infusion versus multiple daily insulin injections in type 1 diabetes: a meta-analysis

  • Matteo Monami
  • Caterina Lamanna
  • Niccolò Marchionni
  • Edoardo Mannucci
Original Article

Abstract

Continuous subcutaneous insulin infusion (CSII) is considered an option for type 1 diabetic patients unsatisfactorily controlled with multiple daily injections (MDI). Short-acting analogs are superior to regular human insulin in CSII. This meta-analysis is aimed at assessing the advantages of short-acting analog-based CSII over MDI in type 1 diabetes. Randomized clinical trials (RCTs) comparing CSII (with analogs) and MDI for at least 12 weeks in type 1 diabetic patients were retrieved, assessing between-group differences in HbA1c and incidence of hypoglycemia. A total of 11 RCTs was included in the analysis. CSII was associated with a significant improvement of HbA1c in comparison with MDI (standardized difference in mean: −0.3 [−0.4;−0.1]%; P < 0.001). No significant difference was observed in the rate of severe hypoglycemic episodes. The reduction of HbA1c with CSII was evident in trials enrolling patients with mean age greater than 10 years, but not in younger children. Available data justify the use of CSII for basal-bolus insulin therapy in type 1 diabetic patients unsatisfactorily controlled with MDI.

Keywords

Insulin therapy Clinical science Humans 

Notes

Acknowledgments

We gratefully acknowledge the technical support of Mrs. Rossella Del Bianco and Dr. Cristina Marchi in the preparation and revision of the manuscript.

Conflict of interest statement

No financial supports were requested from this manuscript and authors did not receive any compensation for their contribution.

References

  1. 1.
    Pickup JC, Renard E (2008) Long-acting insulin analogs versus insulin pump therapy for the treatment of type 1 and type 2 diabetes. Diabetes Care 31(Suppl 2):S140–S145CrossRefPubMedGoogle Scholar
  2. 2.
    Weissberg-Benchell J, Ntisdel-Lomaglio J, Seshadri R (2003) Insulin pump therapy: a meta-analysis. Diabet Care 26:1079–1087CrossRefGoogle Scholar
  3. 3.
    Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR (2006) Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev CD003287Google Scholar
  4. 4.
    Colquitt J, Royle P, Waugh N (2003) Are analogue insulins better than soluble in continuous subcutaneous insulin infusion? Results of a meta-analysis. Diabet Med 20:863–866CrossRefPubMedGoogle Scholar
  5. 5.
    Siebenhofer A, Plank J, Berghold A, Jeitler K, Horvath K, Narath M, Gfrerer R, Pieber TR (2006) Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus. Cochrane Database Syst Rev CD003287Google Scholar
  6. 6.
    Fox LA, Buckloh LM, Smith SD, Wysocki T, Mauras N (2005) A randomized controlled trial of insulin pump therapy in young children with type 1 diabetes. Diabet Care 28:1277–1281CrossRefGoogle Scholar
  7. 7.
    DiMeglio LA, Pottorff TM, Boyd SR, France L, Fineberg N, Eugster EA (2004) A randomized, controlled study of insulin pump therapy in diabetic preschoolers. J Pediatr 145:380–384CrossRefPubMedGoogle Scholar
  8. 8.
    Hanaire-Broutin H, Melki V, Bessieres-Lacombe S, Tauber JP (2000) Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens using insulin lispro in type 1 diabetic patients on intensified treatment: a randomized study. The Study Group for the Development of Pump Therapy in Diabetes. Diabet Care 23:1232–1235CrossRefGoogle Scholar
  9. 9.
    Hoogma RP, Hammond PJ, Gomis R, Kerr D, Bruttomesso D, Bouter KP, Wiefels KJ, de la CH, Schweitzer DH, Pfohl M, Torlone E, Krinelke LG, Bolli GB (2006) Comparison of the effects of continuous subcutaneous insulin infusion (CSII) and NPH-based multiple daily insulin injections (MDI) on glycaemic control and quality of life: results of the 5-nations trial. Diabet Med 23:141–147CrossRefPubMedGoogle Scholar
  10. 10.
    Opipari-Arrigan L, Fredericks EM, Burkhart N, Dale L, Hodge M, Foster C (2007) Continuous subcutaneous insulin infusion benefits quality of life in preschool-age children with type 1 diabetes mellitus. Pediatr Diabet 8:377–383CrossRefGoogle Scholar
  11. 11.
    Thomas RM, Aldibbiat A, Griffin W, Cox MA, Leech NJ, Shaw JA (2007) A randomized pilot study in Type 1 diabetes complicated by severe hypoglycaemia, comparing rigorous hypoglycaemia avoidance with insulin analogue therapy, CSII or education alone. Diabet Med 24:778–783CrossRefPubMedGoogle Scholar
  12. 12.
    Tsui E, Barnie A, Ross S, Parkes R, Zinman B (2001) Intensive insulin therapy with insulin lispro: a randomized trial of continuous subcutaneous insulin infusion versus multiple daily insulin injection. Diabet Care 24:1722–1727CrossRefGoogle Scholar
  13. 13.
    Wilson DM, Buckingham BA, Kunselman EL, Sullivan MM, Paguntalan HU, Gitelman SE (2005) A two-center randomized controlled feasibility trial of insulin pump therapy in young children with diabetes. Diabet Care 28:15–19CrossRefGoogle Scholar
  14. 14.
    Weintrob N, Benzaquen H, Galatzer A, Shalitin S, Lazar L, Fayman G, Lilos P, Dickerman Z, Phillip M (2003) Comparison of continuous subcutaneous insulin infusion and multiple daily injection regimens in children with type 1 diabetes: a randomized open crossover trial. Pediatrics 112:559–564CrossRefPubMedGoogle Scholar
  15. 15.
    Pozzilli P, Crino A, Schiaffini R, Manfrini S, Fioriti E, Coppolino G, Pitocco D, Visalli N, Corbi S, Spera S, Suraci C, Cervoni M, Matteoli MC, Patera IP, Ghirlanda G (2003) A 2-year pilot trial of continuous subcutaneous insulin infusion versus intensive insulin therapy in patients with newly diagnosed type 1 diabetes (IMDIAB 8). Diabet Technol Ther 5:965–974CrossRefGoogle Scholar
  16. 16.
    Bruttomesso D, Crazzolara D, Maran A, Costa S, Dal PM, Girelli A, Lepore G, Aragona M, Iori E, Valentini U, Del PS, Tiengo A, Buhr A, Trevisan R, Baritussio A (2008) In Type 1 diabetic patients with good glycaemic control, blood glucose variability is lower during continuous subcutaneous insulin infusion than during multiple daily injections with insulin glargine. Diabet Med 25:326–332CrossRefPubMedGoogle Scholar
  17. 17.
    DeVries JH, Snoek FJ, Kostense PJ, Masurel N, Heine RJ (2002) A randomized trial of continuous subcutaneous insulin infusion and intensive injection therapy in type 1 diabetes for patients with long-standing poor glycemic control. Diabet Care 25:2074–2080CrossRefGoogle Scholar
  18. 18.
    Doyle EA, Weinzimer SA, Steffen AT, Ahern JA, Vincent M, Tamborlane WV (2004) A randomized, prospective trial comparing the efficacy of continuous subcutaneous insulin infusion with multiple daily injections using insulin glargine. Diabet Care 27:1554–1558CrossRefGoogle Scholar
  19. 19.
    Retnakaran R, Hochman J, DeVries JH, Hanaire-Broutin H, Heine RJ, Melki V, Zinman B (2004) Continuous subcutaneous insulin infusion versus multiple daily injections: the impact of baseline A1c. Diabet Care 27:2590–2596CrossRefGoogle Scholar
  20. 20.
    Jeitler K, Horvath K, Berghold A, Gratzer TW, Neeser K, Pieber TR, Siebenhofer A (2008) Continuous subcutaneous insulin infusion versus multiple daily insulin injections in patients with diabetes mellitus: systematic review and meta-analysis. Diabetologia 51:941–951CrossRefPubMedGoogle Scholar
  21. 21.
    Monami M, Marchionni N, Mannucci E (2009) Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes. A meta-analysis. Diabetes Obes Metab [Epub ahead of print]Google Scholar
  22. 22.
    Lapolla A, Dalfrà MG, Masin M, Bruttomesso D, Piva I, Crepaldi C, Tortul C, Dalla Barba B, Fedele D (2003) Analysis of outcome of pregnancy in type 1 diabetics treated with insulin pump or conventional insulin therapy. Acta Diabetol 40:143–149CrossRefPubMedGoogle Scholar
  23. 23.
    Cimino A, Valentini U, Rotondi A, Candrina R, Salvi A, Spandrio S, Radaeli E, Giustina G (1987) Continuous basal insulin infusion without premeal boluses in insulin-dependent diabetes mellitus therapy. Acta Diabetol Lat 24:193–198CrossRefPubMedGoogle Scholar
  24. 24.
    Hofmann HM, Weiss PA, Haas JG (1986) Continuous insulin delivery systems for the pregnant diabetic patient. Acta Diabetol Lat 23:201–214CrossRefPubMedGoogle Scholar
  25. 25.
    Gimenez M, Conget I, Nicolau J, Pericot A, Levy I (2007) Outcome of pregnancy in women with type 1 diabetes intensively treated with continuous subcutaneous insulin infusion or conventional therapy. A case-control study. Acta Diabetol 44:34–37CrossRefPubMedGoogle Scholar
  26. 26.
    Colino E, Álvarez MA, Carcavilla A, Alonso M, Ros P, Barrio R (2009) Insulin dose adjustment when changing from multiple daily injections to continuous subcutaneous insulin infusion in the pediatric age group. Acta Diabetol. doi: 10.1007/s00592-009-0103-x
  27. 27.
    Pankowska E, Blazik M, Dziechciarz P, Szypowska A, Szajewska H (2009) Continuous subcutaneous insulin infusion vs. multiple daily injections in children with type 1 diabetes: a systematic review and meta-analysis of randomized control trials. Pediatr Diabet 10(5):2–58Google Scholar

Copyright information

© Springer-Verlag 2009

Authors and Affiliations

  • Matteo Monami
    • 1
  • Caterina Lamanna
    • 1
  • Niccolò Marchionni
    • 1
  • Edoardo Mannucci
    • 1
  1. 1.Section of Geriatric Cardiology, Department of Cardiovascular MedicineAzienda Ospedaliero-Universitaria CareggiFlorenceItaly

Personalised recommendations